Chief Executive Officer
Evozyne CEO Marc Yoskowitz is a veteran biopharma executive known for leading public and private companies through transformative periods of growth.
Prior to joining Evozyne, Yoskowitz was chief strategy officer and executive vice president of life sciences at Tempus AI. He has held executive leadership positions with Pfizer, Hospira and McKinsey & Company.
Yoskowitz has a lengthy track record of business building, P&L leadership, creative deal-making and strategic planning, with a deep reservoir of industry relationships. Over the course of his career, he has served as an operating executive, board member and advisor, leading global and domestic work across all facets of the biopharmaceutical value chain.
He holds a JD from Columbia Law School.